AMERICAN pharmacy giant Walgreens has reported a strong quarter, with its retail division posting sales of US$22.5 billion for the three months to 31 Dec - up 9%.
Weakness in grocery lines was offset by growth in beauty and health-and-wellness categories, while prescription volumes surged.
Chief operating officer Alex Gourley warned, however, that drug-price deflation was inevitable with increased sales of generics.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jan 18
